Skip to main content

Pathfinder Bio

Pathfinder Bio develops engineered enzymes and high-performance biomanufacturing processes using a proprietary ultra-high throughput screening platform. The company measures the performance of billions of enzyme variants simultaneously to rapidly design optimal biocatalysts for sustainable chemical manufacturing, serving molecular biology, diagnostics, and industrial applications.

Nottingham, United Kingdom · HQ
Founded 20223500+ followers
Updated 16 days ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Industrial chemical manufacturing relies heavily on energy-intensive, non-renewable processes that generate significant waste and environmental harm. The transition to a circular bioeconomy requires thousands of new green biomanufacturing processes, but traditional enzyme discovery and optimization methods are slow, costly, and limited in throughput, hindering the development of sustainable alternatives.

Solution

Pathfinder Bio provides a proprietary deep tech platform for the ultra-high throughput measurement of enzyme performance, enabling the rapid discovery and improvement of biocatalysts for sustainable chemical manufacturing. The platform uses engineered bacterial cells to make enzyme variants compete against one another, allowing the company to measure the performance of billions of enzymes simultaneously. This approach generates high-quality data that informs the design of optimal enzyme-based biomanufacturing processes. By combining advanced enzyme engineering with low-cost protein production, Pathfinder Bio makes biotechnology more practical, scalable, and sustainable for industrial applications.

Target Audience

Primary customers are companies in the molecular biology, diagnostics, and industrial biotechnology sectors seeking sustainable enzyme-based solutions for chemical manufacturing and biomanufacturing processes.

Features

  • Ultra-high throughput enzyme screening platform that measures billions of enzyme variants in parallel
  • Engineered bacterial cells that create competitive environments for rapid enzyme performance evaluation
  • Proprietary data generation and analysis pipeline for designing optimal biocatalysts
  • Low-cost protein production methods that improve scalability and economic viability
  • Platform applicable across molecular biology reagents, diagnostics, and industrial biomanufacturing
This profile is AI-generated and may contain inaccuracies.